National and Kapodistrian University of Athens
Υποκλινικός υποθυρεοειδισμός και ορμόνες του λιπώδους ιστού
Abstract
dc:descriptionObjective: Irisin, a newly discovered adipo-myokine, is implicated in the modulation of the adipose phenotype, increasing energy expenditure and ameliorating systemic metabolism. Omentin-1, a newly discovered adipocytokine mainly expressed in the visceral adipose tissue, is decreased in dysmetabolic states and may play an important role in the pathogenesis of coronary vascular disease, particularly, coronary atherosclerosis as an anti-inflammatory molecule. The aim of the present doctoral thesis was to investigate circulating novel adipocytokines: irisin (adipo-myokine) and omentin-1 in subclinical hypothyroidism (SH) and study their associations with cardiometabolic risk factors.Material and Methods: In a large case-control study, serum irisin, omentin-1, insulin resistance and lipid parameters, classic adipokines (adiponectin and leptin), inflammatory and hepatic biomarkers, and cardiovascular risk factors were determined in 120 consecutive patients with SH and 120 healthy controls matched on age (±5 years), gender and date of blood draw (± 1 month). Sixteen patients with SH received L-T4 treatment and, after six months, serum irisin, omentin-1 and other biomarkers were assessed. Serum irisin and omentin-1 were determined using ELISA kits (EK-067-29, Phoenix Pharmaceuticals, Burlingame, CA, USA and RD191100200R, BioVendor, Brno, Czech Republic, respectively).Results: SH cases exhibited significantly higher circulating irisin and lower omentin-1 than controls (p<0.001). In all participants, irisin was positively associated with TSH, anti-TG, HOMA-IR, C-peptide, lipid and inflammatory biomarkers, leptin and cardiovascular risk factors, including Framigham score and apolipoprotein B/apolipoprotein A-I. Irisin was negatively correlated with adiponectin, HDL-C and thyroid hormones. Circulating omentin-1 was negatively correlated with somatometric indices, TSH, anti-thyroid antibodies, metabolic and inflammatory biomarkers, leptin and cardiovascular risk factors, including Framigham score. On the contrary, omentin-1 was positively associated with adiponectin, thyroid hormones and HDL-C. Serum irisin and omentin-1 were independently associated with SH, above and beyond body mass index, thyroid autoimmunity, family history of thyroid disease and cardiometabolic risk factors (p=0.02 and p<0.001, respectively). TSH was an independent predictor of both circulating irisin (p=0.003) and omentin-1 (p<0.001). L-T4 therapy did not reverse considerably hyperirisinemia and hypoomentinemia in treated SH patients (p=0.09 and p=0.07, respectively).Conclusions: Irisin may represent an adipo-myokine counterbalancing a potential, gradual deterioration of lipid metabolism and insulin sensitivity in SH as well as reflecting a protective compensatory mechanism against oxidative muscle and thyroid cell stress. Omentin-1 like adiponectin may exhibit anti-inflammatory and anti-atherogenic properties. Omentin seems to be one of the ‘‘beneficial’’ adipocytokines and a potential biomarker of atherosclerosis risk in SH as well as a future therapeutic target. More mechanistic and prospective studies shedding light on the pathogenetic role of irisin and omentin-1 in SH are needed to confirm and extend these data.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stratigou, Theodora
- Στρατηγού, Θεοδώρα
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44678